Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.
1. A method of inducing a cross-reactive anti-HIV-1 immune response in a subject comprising contacting said subject with an immunogenic composition comprising a GBV-C E2 polypeptide or fragment thereof comprising an epitope defined by GGAGLTGGFYEPLVRRC (SEQ ID NO:7) dispersed in a pharmaceutical carrier, buffer or medium.
2. The method of claim 1 , wherein said immunogenic composition further comprises an adjuvant.
3. The method of claim 1 , wherein said immunogenic composition comprises a full length GBV-C E2 polypeptide.
4. The method of claim 1 , wherein said immunogenic composition comprises GBV-C E2 fragment.
5. The method of claim 1 , wherein the polypeptide or fragment is linked to a carrier molecule.